Fluid Overload and Inflammation-A Vicious Cycle

Seminars in Dialysis

Volumn 26, Issue 1, 2013, Pages 31-35

  Reyes Bahamonde, Joselyn ^a   Raimann, Jochen G ^a   Thijssen, Stephan ^a   Levin, Nathan W ^a   Kotanko, Peter ^a  

^a RENAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

BODY FLUID; CHRONIC KIDNEY FAILURE; EDITORIAL; HEALTH; HUMAN; INFLAMMATION; METABOLISM; MORBIDITY;

BIOLOGICAL MARKERS; BODY FLUIDS; HUMANS; INFLAMMATION; MORBIDITY; RENAL INSUFFICIENCY, CHRONIC; WORLD HEALTH;

EID: 84872914848     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12024     Document Type: Editorial

References (65)

1. Pecoits-Filho R, Lindholm B, Axelsson J, Stenvinkel P: Update on interleukin-6 and its role in chronic renal failure. Nephrol Dial Transplant 18:1042-1045, 2003
2. Pecoits-Filho R, Heimburger O, Barany P, Suliman M, Fehrman-Ekholm I, Lindholm B, Stenvinkel P: Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 41:1212-1218, 2003
3. Shin SK, Noh H, Kang SW, Seo BJ, Lee IH, Song HY, Choi KH, Ha SK, Lee HY, Han DS: Risk factors influencing the decline of residual renal function in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 19:138-142, 1999
4. Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD: Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 80:299-307, 2004
5. Demirci MS, Demirci C, Ozdogan O, Kircelli F, Akcicek F, Basci A, Ok E, Ozkahya M: Relations between malnutrition-inflammation-atherosclerosis and volume status. The usefulness of bioimpedance analysis in peritoneal dialysis patients. Nephrol Dial Transplant 26:1708-1716, 2011
6. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999
7. Marnell L, Mold C, Du Clos TW: C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 117:104-111, 2005
8. Virdis A, Schiffrin EL: Vascular inflammation: a role in vascular disease in hypertension? Curr Opin Nephrol Hypertens 12:181-187, 2003
9. Wrigley BJ, Lip GY, Shantsila E: The role of monocytes and inflammation in the pathophysiology of heart failure. Eur J Heart Fail 13:1161-1171, 2011
10. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM: Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 81:627-635, 1997
11. Maier HJ, Schips TG, Wietelmann A, Kruger M, Brunner C, Sauter M, Klingel K, Bottger T, Braun T, Wirth T: Cardiomyocyte-specific IkappaB kinase (IKK)/NF-kappaB activation induces reversible inflammatory cardiomyopathy and heart failure. Proc Natl Acad Sci U S A 109:11794-11799, 2012
12. Sigrist M, Bungay P, Taal MW, McIntyre CW: Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant 21:707-714, 2006
13. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM: Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 32:570-574, 1998
14. Blacher J, Safar ME, Guerin AP, Pannier B, Marchais SJ, London GM: Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 63:1852-1860, 2003
15. Ozkahya M, Ok E, Toz H, Asci G, Duman S, Basci A, Kose T, Dorhout Mees EJ: Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant 21:3506-3513, 2006
16. USRDS: United States Renal Data System: 2011 Annual Data Report.
17. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Schiller BM, Yang PC, Rajagopalan S: Determinants of left ventricular mass in patients on hemodialysis: frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging 5:251-261, 2012
18. Levin A, Singer J, Thompson CR, Ross H, Lewis M: Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 27:347-354, 1996
19. Chen SC, Chang JM, Liu WC, Huang JC, Tsai JC, Lin MY, Su HM, Hwang SJ, Chen HC: Echocardiographic parameters are independently associated with increased cardiovascular events in patients with chronic kidney disease. Nephrol Dial Transplant 27:1064-1070, 2012
20. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME: Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 12:2759-2767, 2001
21. Pecoits-Filho R, Bucharles S, Barberato SH: Diastolic heart failure in dialysis patients: mechanisms, diagnostic approach, and treatment. Semin Dial 25:35-41, 2012
22. Glassock RJ, Pecoits-Filho R, Barberato SH: Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 4(Suppl. 1):S79-S91, 2009
23. Kolb J, Kitzler TM, Tauber T, Morris N, Skrabal F, Kotanko P: Proto-dialytic cardiac function relates to intra-dialytic morbid events. Nephrol Dial Transplant 26:1645-1651, 2011
24. Stegmayr BG: Ultrafiltration and dry weight-what are the cardiovascular effects? Artif Organs 27:227-229, 2003
25. Eldehni MT, McIntyre CW: Are there neurological consequences of recurrent intradialytic hypotension? Semin Dial 25:253-256, 2011
26. Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, von Haehling S, Schroedl W, Karhausen T, Doehner W, Rauchhaus M, Poole-Wilson P, Volk HD, Lochs H, Anker SD: Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 50:1561-1569, 2007
27. Dorairajan S, Chockalingam A, Misra M: Myocardial stunning in hemo dialysis: what is the overall message? Hemodial Int 14:447-450, 2010
28. McIntyre CW, Burton JO, Selby NM, Leccisotti L, Korsheed S, Baker CS, Camici PG: Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 3:19-26, 2008
29. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 4:1925-1931, 2009
30. Tisler A, Akocsi K, Borbas B, Fazakas L, Ferenczi S, Gorogh S, Kulcsar I, Nagy L, Samik J, Szegedi J, Toth E, Wagner G, Kiss I: The effect of frequent or occasional dialysis-associated hypotension on survival of patients on maintenance haemodialysis. Nephrol Dial Transplant 18:2601-2605, 2003
31. Dou Y, Zhu F, Kotanko P: Assessment of extracellular fluid volume and fluid status in hemodialysis patients: current status and technical advances. Semin Dial 25:377-387, 2012
32. Penne EL, Sergeyeva O: Sodium gradient: a tool to individualize dialysate sodium prescription in chronic hemodialysis patients? Blood Purif 31:86-91, 2011
33. Kooman JP, van der Sande FM, Leunissen KM: Role of sodium and volume in the pathogenesis of hypertension in dialysis patients. Reflections on pathophysiological mechanisms. Blood Purif 22:55-59, 2004
34. Donauer J, Kolblin D, Bek M, Krause A, Bohler J: Ultrafiltration profiling and measurement of relative blood volume as strategies to reduce hemodialysis-related side effects. Am J Kidney Dis 36:115-123, 2000
35. Chan C, Floras JS, Miller JA, Pierratos A: Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 17:1518-1521, 2002
36. Wizemann V, Wabel P, Chamney P, Zaluska W, Moissl U, Rode C, Malecka-Masalska T, Marcelli D: The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 24:1574-1579, 2009
37. Lindley EJ: Reducing sodium intake in hemodialysis patients. Semin Dial 22:260-263, 2009
38. Keen ML, Gotch FA: The association of the sodium "setpoint" to interdialytic weight gain and blood pressure in hemodialysis patients. Int J Artif Organs 30:971-979, 2007
39. Burnier M, Phan O, Wang Q: High salt intake: a cause of blood pressure-independent left ventricular hypertrophy? Nephrol Dial Transplant 22:2426-2429, 2007
40. Ritz E, Dikow R, Morath C, Schwenger V: Salt-a potential 'uremic toxin'? Blood Purif 24:63-66, 2006
41. Sanders PW: Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension 43:142-146, 2004
42. Rahman SH, Ammori BJ, Holmfield J, Larvin M, McMahon MJ: Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis. J Gastrointest Surg 7: 26-35; discussion 35-26, 2003
43. Kotanko P, Carter M, Levin NW: Intestinal bacterial microflora-a potential source of chronic inflammation in patients with chronic kidney disease. Nephrol Dial Transplant 21:2057-2060, 2006
44. Ritz E: Intestinal-renal syndrome: mirage or reality? Blood Purif 31:70-76, 2011
45. Lundsgaard-Hansen P, Blauhut B: [Relation of hypoxia and edema of the intestinal wall and skin to colloid osmotic pressure]. Anaesthesist 37:112-119, 1988
46. McIntyre CW, Harrison LE, Eldehni MT, Jefferies HJ, Szeto CC, John SG, Sigrist MK, Burton JO, Hothi D, Korsheed S, Owen PJ, Lai KB, Li PK: Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol 6:133-141, 2011
47. Guarner F, Malagelada JR: Gut flora in health and disease. Lancet 361:512-519, 2003
48. Goncalves S, Pecoits-Filho R, Perreto S, Barberato SH, Stinghen AE, Lima EG, Fuerbringer R, Sauthier SM, Riella MC: Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients. Nephrol Dial Transplant 21:2788-2794, 2006
49. Yu Z, Tan BK, Dainty S, Mattey DL, Davies SJ: Hypoalbuminaemia, systemic albumin leak and endothelial dysfunction in peritoneal dialysis patients. Nephrol Dial Transplant, 2012 Apr 19. [Epub ahead of print]
50. Ford EG, Jennings LM, Andrassy RJ: Serum albumin (oncotic pressure) correlates with enteral feeding tolerance in the pediatric surgical patient. J Pediatr Surg 22:597-599, 1987
51. Arques S, Ambrosi P: Human serum albumin in the clinical syndrome of heart failure. J Card Fail 17:451-458, 2011
52. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD: Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353:1838-1842, 1999
53. Middlekauff HR, Mark AL: The treatment of heart failure: the role of neurohumoral activation. Intern Med 37:112-122, 1998
54. Doshi M, Murray PT: Approach to intradialytic hypotension in intensive care unit patients with acute renal failure. Artif Organs 27:772-780, 2003
55. Rubinger D, Revis N, Pollak A, Luria MH, Sapoznikov D: Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol Dial Transplant 19:2053-2060, 2004
56. Chan CT, Levin NW, Chertow GM, Larive B, Schulman G, Kotanko P: Determinants of cardiac autonomic dysfunction in ESRD. Clin J Am Soc Nephrol 5:1821-1827, 2010
57. Fiebeler A, Muller DN, Shagdarsuren E, Luft FC: Aldosterone, mineralocorticoid receptors, and vascular inflammation. Curr Opin Nephrol Hypertens 16:134-142, 2007
58. Rubinger D, Revis N, Pollak A, Luria MH, Sapoznikov D: Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol Dial Transplant 19:2053-2060, 2004
59. Nord E, Danovitch GM: Vasopressin response in haemodialysis patients. Proc Eur Dial Transplant Assoc 16:238-243, 1979
60. Zoccali C, Mallamaci F, Ciccarelli M, Parlongo S, Salnitro F, Curatola A: The reflex control of vasopressin in haemodialysis patients. Nephrol Dial Transplant 6:631-636, 1991
61. Fenske W, Wanner C, Allolio B, Drechsler C, Blouin K, Lilienthal J, Krane V: Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus. J Am Soc Nephrol 22:782-790, 2011
62. Thijssen S, Raimann JG, Usvyat LA, Levin NW, Kotanko P: The evils of intradialytic sodium loading. Contrib Nephrol 171:84-91, 2011
63. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS: In-center hemodialysis six times per week versus three times per week. N Engl J Med 363:2287-2300, 2010
64. Hasper D, Hummel M, Kleber FX, Reindl I, Volk HD: Systemic inflammation in patients with heart failure. Eur Heart J 19:761-765, 1998
65. Sato Y, Takatsu Y, Kataoka K, Yamada T, Taniguchi R, Sasayama S, Matsumori A: Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation. Clin Cardiol 22:811-813, 1999